Investors

Recent News

AXIM® Biotechnologies Issues Update Letter to Shareholders

SAN DIEGO, May 13, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and cannabinoid research, announced today that it has issued a letter...

Email Alerts

Stay informed and receive company updates straight to your inbox

Latest Annual Filing

Fiscal Year Ended Dec 31, 2019